RHESONATIV

This brand name is authorized in Austria, Ecuador, Estonia, Finland, Croatia, Ireland, Lithuania, Malta, New Zealand, Poland, Romania, Tunisia, South Africa

Active ingredients

The drug RHESONATIV contains one active pharmaceutical ingredient (API):

1 Anti-D (rh) immunoglobulin UNII RX2MM64U68 - HUMAN IMMUNOGLOBULINS

Human anti-D immunoglobulin contains specific antibodies (IgG) against the Rh(D) antigen of human erythrocytes. It can also contain antibodies to other Rh antigens, e.g. anti-Rh C antibodies. The mechanism by which anti-D immunoglobulin suppresses immunisation to Rh(D) positive red cells is not known. Read about Anti-D (rh) immunoglobulin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
RHESONATIV Solution for injection	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J06BB01	Anti-D (rh) immunoglobulin	J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06B Immunoglobulins → J06BB Specific immunoglobulins
Discover more medicines within J06BB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 146-MBE-1119
Country: EE	Ravimiamet	Identifier(s): 1295782, 1295816, 1295827, 1584828
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 063818
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-584583753
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1025648, 1025649, 1031947
Country: MT	Medicines Authority	Identifier(s): MA1219/01001, MA1219/01002
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 12509, 12510
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100193540, 100375949
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65901001, W65901002, W65901003, W65902001, W65902002, W65902003
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 2103021
Country: ZA	Health Products Regulatory Authority	Identifier(s): 51/30.1/0996